Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GLP-1 analogue liraglutide on inflammation in diabetic kidney disease
2012-005482-12Phase 3Completed
- Sponsor
- University College Dublin
- Start
- Jan 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in diabetic glomerulosclerosis, type 2 diabetes mellitus (T2DM), sponsored by University College Dublin. Started Jan 2013; status: completed.
02
Drugs
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-005482-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005482-12.